HCA Healthcare Cash Flow from Operating Activities 2012-2026 | HCA

HCA Healthcare annual/quarterly cash flow from operating activities history and growth rate from 2012 to 2026. Cash flow from operating activities can be defined as a company's cash flows from operations.
  • HCA Healthcare cash flow from operating activities for the quarter ending March 31, 2026 was $12.636B, a 20.18% increase year-over-year.
  • HCA Healthcare cash flow from operating activities for the twelve months ending March 31, 2026 was $30.425B, a 19.89% increase year-over-year.
  • HCA Healthcare annual cash flow from operating activities for 2025 was $12.636B, a 20.18% increase from 2024.
  • HCA Healthcare annual cash flow from operating activities for 2024 was $10.514B, a 11.48% increase from 2023.
  • HCA Healthcare annual cash flow from operating activities for 2023 was $9.431B, a 10.67% increase from 2022.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
HCA Healthcare Annual Cash Flow Ops
(Millions of US $)
2025 $12,636
2024 $10,514
2023 $9,431
2022 $8,522
2021 $8,959
2020 $9,232
2019 $7,602
2018 $6,761
2017 $5,426
2016 $5,653
2015 $4,734
2014 $4,448
2013 $3,680
2012 $4,175
2011 $3,933
Sector Industry Market Cap Revenue
Medical Medical Services $110.772B $75.600B
HCA Healthcare Inc. is a provider of healthcare services comprising hospitals and ambulatory sites of care including surgery centers, freestanding ERs, urgent care centers and physician clinics. HCA Healthcare Inc., formerly known as HCA HOLDINGS, is based in NASHVILLE, Tenn.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $134.187B 24.31
CVS Health (CVS) United States $101.670B 11.75
Elevance Health (ELV) United States $68.432B 10.33
Cencora (COR) United States $62.409B 19.63
Natera (NTRA) United States $27.358B 0.00
Labcorp Holdings (LH) United States $21.501B 15.87
DiDi Global (DIDIY) China $18.026B 15.96
Viatris (VTRS) United States $15.685B 5.71
EUROFINS SCIENT (ERFSF) Luxembourg $14.535B 0.00
Medpace Holdings (MEDP) United States $14.094B 32.26
BioMerieux (BMXMF) France $12.476B 0.00
Solventum (SOLV) United States $11.408B 10.78
Revvity (RVTY) United States $10.039B 17.71
BrightSpring Health Services (BTSG) United States $8.774B 43.59
Charles River Laboratories (CRL) United States $8.667B 17.09
ICON (ICLR) Ireland $8.626B 8.56
CochLear (CHEOY) Australia $8.030B 0.00
Sonic Healthcare (SKHHY) Australia $6.905B 0.00
HealthEquity (HQY) United States $6.586B 23.20
Bausch + Lomb (BLCO) Canada $5.877B 32.98
GETINGE (GNGBY) Sweden $5.626B 17.96
Avantor (AVTR) United States $5.388B 8.68
PACS (PACS) United States $5.304B 27.44
Caris Life Sciences,�Inc (CAI) United States $5.101B 0.00
Sotera Health (SHC) United States $4.380B 19.95
Alignment Healthcare (ALHC) United States $4.188B 0.00
Concentras Parent (CON) United States $2.818B 16.12
Organon (OGN) United States $2.299B 2.57
Amplifon S.p.A (AMFPF) Italy $2.275B 13.27
Pediatrix Medical (MD) United States $1.782B 11.11
Establishment Labs Holdings (ESTA) United States $1.765B 0.00
GeneDx Holdings (WGS) United States $1.746B 42.28
Surgery Partners (SGRY) United States $1.671B 41.65
Sonida Senior Living (SNDA) United States $1.544B 0.00
Ardent Health (ARDT) United States $1.345B 5.70
Progyny (PGNY) United States $1.277B 25.08
Ryman Healthcare (RYHTY) New Zealand $1.240B 0.00
InnovAge Holding (INNV) United States $1.113B 164.00
Teladoc Health (TDOC) United States $0.920B 0.00
CareDx (CDNA) United States $0.822B 0.00
GoodRx Holdings (GDRX) United States $0.750B 12.17
Enhabit (EHAB) United States $0.709B 25.89
Nutex Health (NUTX) United States $0.704B 11.25
Omada Health (OMDA) United States $0.672B 0.00
QDM (QDMI) Hong Kong, SAR China $0.604B 99.85
COMPASS Pathways (CMPS) United Kingdom $0.531B 0.00
Embecta (EMBC) United States $0.524B 2.92
Charming Medical (MCTA) Hong Kong, SAR China $0.497B 0.00
CryoPort (CYRX) United States $0.482B 0.00
Auna S.A (AUNA) Luxembourg $0.435B 4.70
SBC Medicals (SBC) United States $0.426B 8.47
Forward Industries (FWDI) United States $0.375B 0.00
Strata Critical Medical (SRTA) United States $0.349B 0.00
Agilon Health (AGL) United States $0.316B 0.00
Shoulder Innovations (SI) United States $0.309B 0.00
Oncology Institute (TOI) United States $0.304B 0.00
So-Young (SY) China $0.262B 0.00
LifeMD (LFMD) United States $0.166B 0.00
Biodesix (BDSX) United States $0.133B 0.00
Beauty Health (SKIN) United States $0.115B 0.00
Ascend Wellness Holdings (AAWH) United States $0.091B 0.00
Park Dental Partners (PARK) United States $0.080B 0.00
Sera Prognostics (SERA) United States $0.077B 0.00
DocGo (DCGO) United States $0.051B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.037B 0.00
Pomdoctor - (POM) China $0.031B 0.00
IceCure Medical (ICCM) Israel $0.026B 0.00
OSR Holdings (OSRH) United States $0.018B 0.00
SeaStar Medical Holding (ICU) United States $0.015B 0.00
Basel Medical Group (BMGL) Singapore $0.011B 0.00
Lifeward (LFWD) United States $0.010B 0.00
XWELL (XWEL) United States $0.009B 0.00
Aclarion (ACON) United States $0.007B 0.00
Synergy CHC (SNYR) United States $0.007B 0.00
Pheton Holdings (PTHL) China $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
Co-Diagnostics (CODX) United States $0.005B 0.00
Intelligent Bio Solutions (INBS) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
INVO Fertility (IVF) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00